Literature DB >> 18161659

Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

J Y Lim1, J Y Cho, Y H Paik, Y S Chang, H G Kim.   

Abstract

Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is one of thecurrently used techniques to identify biomarkers for cancers. This study was planned to establish a system to accurately distinguish gastric cancer patients by using SELDI-TOF-MS. A total of 100 serum samples obtained from 60 individuals with gastric cancer and 40 healthy individuals were screened. Protein expression profiles were expressed on CM10 ProteinChip arrays and analyzed. Peak intensities were analyzed with the Biomarker Wizard software to identify peaks showing significantly different intensities between normal and cancer groups. Classification analysis and construction of decision trees were done with the Biomarker Pattern software 5.0. Seventeen protein peaks showed significant differences between the two groups. The decision tree which gave the highest discrimination included four peaks at mass 5,919, 8,583, 10,286, and 13,758 as splitters. The sensitivity and specificity for classification of the decision tree were 96.7% (58/60) and 97.5% (39/40), respectively. When the protein biomarker pattern was tested on a blinded test set, it yielded a sensitivity of 93.3% (28/30) and a specificity of 90% (18/20). These results suggest that serum protein profiling by the SELDI system may distinguish gastric cancer patients from healthy controls with relatively high sensitivity and specificity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18161659     DOI: 10.1177/172460080702200407

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  7 in total

1.  Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Xiao-Dong Zhu; Fang Su; Zhong-Guo Liang; Ling Li; Song Qu; Xia Liang; Qi Wang; Shi-Xiong Liang; Long Chen
Journal:  Int J Clin Oncol       Date:  2013-09-27       Impact factor: 3.402

Review 2.  Proteomic and metabolic prediction of response to therapy in gastric cancer.

Authors:  Michaela Aichler; Birgit Luber; Florian Lordick; Axel Walch
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

3.  Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.

Authors:  Monika Pietrowska; Lukasz Marczak; Joanna Polanska; Katarzyna Behrendt; Elzbieta Nowicka; Anna Walaszczyk; Aleksandra Chmura; Regina Deja; Maciej Stobiecki; Andrzej Polanski; Rafal Tarnawski; Piotr Widlak
Journal:  J Transl Med       Date:  2009-07-13       Impact factor: 5.531

4.  Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Authors:  Shawn A Ritchie; Pearson W K Ahiahonu; Dushmanthi Jayasinghe; Doug Heath; Jun Liu; Yingshen Lu; Wei Jin; Amir Kavianpour; Yasuyo Yamazaki; Amin M Khan; Mohammad Hossain; Khine Khine Su-Myat; Paul L Wood; Kevin Krenitsky; Ichiro Takemasa; Masakazu Miyake; Mitsugu Sekimoto; Morito Monden; Hisahiro Matsubara; Fumio Nomura; Dayan B Goodenowe
Journal:  BMC Med       Date:  2010-02-15       Impact factor: 8.775

Review 5.  Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers.

Authors:  Ken Herrmann; Axel Walch; Benjamin Balluff; Marc Tänzer; Heinz Höfler; Bernd J Krause; Markus Schwaiger; Helmut Friess; Roland M Schmid; Matthias P A Ebert
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-03

6.  Serum biomarker panels for the diagnosis of gastric adenocarcinoma.

Authors:  H S Ahn; Y S Shin; P J Park; K N Kang; Y Kim; H-J Lee; H-K Yang; C W Kim
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

Review 7.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.